ulrich medical USA® Announces Full U.S. Commercial Launch of the Momentum® MIS Posterior Spinal Fixation System

ulrich medical USA, the pioneer in expandable corpectomy devices and a market leader in spine technology, today announced at the North American Spine Society 38th Annual Meeting, the full U.S. commercial launch of the Momentum MIS Posterior Spinal Fixation System. Momentum MIS was initially launched at the beginning of the year and the limited launch phase recently came to a successful completion.

“I have been very pleased with the new Momentum MIS system,” said Grant Buttram, MD, MBA, neurosurgeon at UNC Health. “It is streamlined, intuitive and performs exactly as a MIS system should. The addition of compatibility with Medtronic’s StealthStation will allow surgeons who prefer navigating their procedures to offer their patients a reliable fixation option.”

Momentum MIS provides ulrich medical USA with a percutaneous solution to address the growing minimally invasive surgery market. Its design offers a comprehensive tab-based system with a narrow profile, extended screw tabs, removable rings for reinforced support, and integrated reduction. The system also features a novel guide-wire lock, and shares the benefits of the successful Momentum® posterior fixation platform that includes conical screws with cannulated, fenestrated screw options.

“Momentum MIS is truly among the leading next generation MIS solutions on the market in terms of performance and adaptability”, said Jim Bruty, Chief Operating Officer at ulrich medical USA. “The launch of this system is a significant milestone in the company’s evolution toward offering a comprehensive spine portfolio for its surgeon customers.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version